Both in Pharmaceuticals
BridgeBio Oncology Therapeutics vs PepGen
Over the past year BBOT returned −81.0% and PEPG returned −45.9%; their daily moves had a correlation of 0.11.
BBOT −81.0% PEPG −45.9%Growth of $1, one year, split-adjusted
| Metric | BBOT | PEPG |
|---|---|---|
| Price | $2.30 | $2.45 |
| Market cap | $184.4M | $169.7M |
| Today | −0.86% | −0.41% |
| 1 month | −34.3% | +6.1% |
| 6 months | −72.4% | +32.8% |
| Year to date | −81.6% | −62.4% |
| 1 year | −81.3% | −45.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.7M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 87.9% | 67.7% |
| Short % of float | 13.9% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).